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Abstract
Background: The burden of cardiovascular disease (CVD) in Britain is concentrated in inner-city
areas such as Sandwell, which is home to a diverse multi-ethnic population. Current guidance for
CVD risk screening is not established, nor are there specific details for ethnic minorities. Given the
disparity in equitable healthcare for these groups, we developed a 'tailored' and systematic
approach to CVD risk screening within communities of the Sandwell locality. The key anticipated
outcomes were the numbers of participants from various ethnic backgrounds attending the health
screening events and the prevalence of known and undiagnosed CVD risk within ethnic groups.
Methods: Data was collected during 10 health screening events (September 2005 and July 2006),
which included an assessment of raised blood pressure, overweight, hyperlipidaemia, impaired
fasting glucose, smoking habit and the 10 year CVD risk score. Specific features of our approach
included (i) community involvement, (ii) a clinician who could deliver immediate attention to
adverse findings, and (iii) the use of an interpreter.
Results: A total of 824 people from the Sandwell were included in this study (47% men, mean age
47.7 years) from community groups such as the Gujarati Indian, Punjabi Indian, European Caucasian,
Yemeni, Pakistani and Bangladeshi. A total of 470 (57%) individuals were referred to their General
Practitioner with a report of an increased CVD score – undetected high blood pressure in 120
(15%), undetected abnormal blood glucose in 70 (8%), undetected raised total cholesterol in 149
(18%), and CVD risk management review in 131 (16%).
Conclusion: Using this systematic and targeted approach, there was a clear demand for this
service from people of various ethnic backgrounds, of whom, one in two needed review from
primary or secondary healthcare. Further work is required to assess the accuracy and clinical
benefits of this community health screening approach.
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Background
Cardiovascular disease (CVD) is the leading cause of
death in Britain [1], but compared to the general popula-
tion, the burden is more prominent amongst the country's
ethnic minorities [2]. This excess of CVD mortality relates
to the morbid affliction of its determinants amongst
migrant communities, most notably the influence of dia-
betes and hypertension, which frequents South Asian
(those people originating from the Indian subcontinent,
including Indian, Pakistani, Bangladeshi and Sri Lankan
groups) and African-Caribbean groups [3-6]. Strategies for
the prevention of CVD focus on health promotion and the
early recognition, assessment and reduction of risk factors
in asymptomatic individuals [7]. CVD risk screening guid-
ance that is specific for ethnic minorities is not estab-
lished, and there is insufficient evidence to develop a
consensus approach for ethnically specific CVD manage-
ment and prevention.
An outline of the problem
National guidelines from the National Service Framework
[8], the National Institute for Clinical Excellence [9] and
the Quality and Outcomes Framework [10] relating to
coronary heart disease (CHD) prioritise risk management
and amongst those individuals with existing CHD, or co-
morbidities. However, specific guidance on the strategies
for the assessment of CVD risk in asymptomatic individu-
als is not available [11]. Previously, research on CVD risk
in a random sample of South Asians in Sandwell [12]
revealed that more than 50% of hypertensives and diabet-
ics were newly diagnosed, highlighting a missed opportu-
nity for the primary prevention of CVD in this high risk
group. By comparing immigrant communities in Britain
to their contemporaries living in their country of origin,
studies illustrate the insidious change in CVD risk
amongst migrants, which is not evident from absolute
measures of serum cholesterol, blood pressure and
anthropometry in these groups [12-14]. The implication
is that the burden of dyslipidaemia, hypertension and dia-
betes is likely to be underestimated in ethnic minorities in
Britain. Moreover, national data suggests that current
healthcare services are flawed with regard to equitable
healthcare for ethnic communities in Britain [15], with
one specific example being the availability and utility of
bilingual services [2].
A culturally specific approach
The initiative to begin health screens within local commu-
nities was first realised as an outcome of ongoing research
in a cohort of randomly selected Indian Gujaratis in 2002
[12]. This was followed by an 'ad hoc' two-year pro-
gramme of 'in kind' CVD risk screens within the broader
South Asian communities and the general population of
Sandwell. With experiences gleaned from these screens,
the following features were deemed essential for the suc-
cess of any community health screening event: (i) the
involvement of the local community to develop and
advertise the health screening events, (ii) the presence of
an experienced physician with special interest in CVD (to
deliver immediate attention to adverse findings), and (iii)
the use of an interpreter and multi-lingual staff, who,
where possible, were available to assist prospective partic-
ipants to make informed choices in their involvement in
the health screen, and improve communication during
consultations.
The key anticipated outcomes were the numbers of partic-
ipants from various ethnic backgrounds attending the
health screens and the prevalence of known and undiag-
nosed CVD risk within ethnic groups. The evidence col-
lected would then be used to determine whether it was
feasible to adopt community health screening events into
primary prevention services that operate to reduce CVD
risk.
Methods
Setting
In the UK, CVD mortality rates in inner city areas such as
Sandwell are the highest nationally for England and Wales
[1]. Information from the 2001 census reveals that
between 20 and 25% of the 300,000 population of Sand-
well are from ethnic minority groups (including Bangla-
deshi (1.21%), Indian (9.14%) and Pakistani (2.95%)
populations). Sandwell is amongst the most severely
deprived areas in the UK, with the Carstairs Index,
Townsend Score, Underprivileged Area Index and Local
Deprivation Index all in the upper quintile for the major-
ity of the electoral wards [1]. Compared nationally, health
in Sandwell is generally poor, where fruit and vegetable
consumption are significantly lower, whilst smoking and
obesity rates are markedly higher in the adult population
[16].
Development of Health Screening Events
Given the burden of CVD in the area, and the broad multi-
ethnic population, a Community Health Network
(CHN), a public health initiative team from Sandwell Pri-
mary Healthcare Trust, who respond to healthcare con-
cerns and needs raised by Black and Minority Ethnic
(BME) groups, operate in the locality. The CHN team was
engaged in this 'Healthy Hearts Project' to ensure the inte-
gration of local communities (Bangladeshi, Indian
Gujarati, Pakistani, Indian Punjabi and the Yemeni) in the
development and advertisement of health screening
events. Specifically, CHN leads for each community pro-
moted health screening events within the main ethnic
minority groups in Sandwell: Bangladeshi (3 events),
Pakistani (1 event), Gujarati (1 event), Indian Punjabi (2
events) and Yemeni (1 event) within community venues.
The promotion of the health screening event includedBMC Health Services Research 2007, 7:192 http://www.biomedcentral.com/1472-6963/7/192
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posters (translated as appropriate) within community
halls, local GP clinics and healthcare centres (through the
Primary Care Trust) and the advertisement of the event in
the form of circulars distributed by the community (2
weeks before the event by the CHN leader). Subjects were
advised to come fasting (no food or drink from 10 pm the
previous evening) if they wanted their blood sugar
assessed as part of a diabetes risk assessment. It was antic-
ipated that 100 individuals would attend each event. Both
the circulars and the posters contained identical informa-
tion, requesting men and women aged from 25 years to
attend health screening events. In addition, there were
two events within public spaces (Sandwell Community
show) that focussed on the attendance of the general
European Caucasian population (advertisement was
through similar posters distributed to local GP clinics and
healthcare centres, with circulars distributed on the day of
the event). Our target population of 1000 people was to
include those people who were representative of men and
women within the five main ethnic groups in Sandwell
(100 in each gender group). Using this targeted and sys-
tematic approach, these series of ten community health
screening events, between September 2005 and July 2006,
called the 'Healthy Hearts Project', were conducted to col-
lect information on the performance of these health
screens within ethnic communities.
The 'Healthy Hearts' Team
The staff of the Healthy Hearts team were composed of
health professionals working within the Sandwell and
West Birmingham Hospitals NHS Trust, specifically Sand-
well Medical Research Unit and the Haemostasis, Throm-
bosis and Vascular Biology Unit. The staff of the healthy
hearts team varied in accordance to the specific needs of
the community group targeted (i.e an all-female team was
a requisite for two events). The Healthy Hearts team
included a hospital-based interpreter or an appropriate
CHN leader to facilitate the informed consent process.
The team consisted of physicians, nurses, and researchers,
who were experienced in the assessment of CVD risk.
Procedure
The health screening events were started between 8 am to
9 am, and lasted for five hours. People attended the health
screening event in a "fasting" state. Firstly, written
informed consent was obtained, followed by demo-
graphic information including their fasting status, ethnic-
ity, general practitioner details (where the subject had
consented for this information to be included) and a med-
ical history questionnaire relating to cardiovascular health
and diabetes.
Following consent, participants were invited to be
assessed for the measurement of body weight (Seca floor
scales) and height (Leicester height measure, Seca Ltd, Bir-
mingham UK), where the subject was measured without
shoes in light clothing, and advised to stand in a posture
to accommodate their heads to be in the vertex plane for
height assessment. Body mass index was calculated as
weight(kg)/height(meters)
squared. Capillary blood cholesterol and glucose were
measured using the Roche Accutrend GC monitor (Roche
Diagnostics, Welwyn Garden City, UK), using methodol-
ogy approved by the Royal Pharmaceutical Society of
Great Britain (2003). The medical history questionnaire
was completed by the nurse or researcher (with interpret-
ing services used as appropriate), and the blood pressure
was measured after the patient was seated for more than
five minutes using the OMRON 705CP (Omron Health-
care Europe, Mannheim, Germany), a semi automated
blood pressure monitor used with appropriate cuff sizes.
The blood pressure was measured in triplicate in accord-
ance with the British Hypertension Society guidelines
[17], where the mean of the last two measurements was
used as the final reading. Hypertension was defined by
either self-reported history (participants knowledge of a
diagnosis of hypertension by a doctor or a health profes-
sional), or the use of antihypertensive medication or a
systolic blood pressure > 140 mmHg, or a diastolic blood
pressure > 90 mmHg. Current and previous smoking
habit (more than 100 cigarettes smoked in total) was
assessed amongst both men and women. New hyperlipi-
daemia was defined as a total cholesterol > 5 mmol/l and
the absence of any history of lipid lowering medication.
Diabetes was defined as a self-reported history (partici-
pants knowledge of a diagnosis of diabetes by a doctor or
a health professional) and newly detected glucose intoler-
ance was defined as a fasting capillary blood sugar > 6
mmol, and the absence diabetes or use hypoglycaemic
medication/insulin.
Using the coronary risk calculator of the European Society
of Cardiology (ESC) the absolute risk (%) of developing
non fatal coronary heart disease or coronary death over
the next 10 years was estimated. This algorithm was
derived from the European risk charts derived from
SCORE estimate risk of cardiovascular death, based on the
risk factors: age, gender, smoking habit, blood pressure
and blood cholesterol [18].
The information was recorded on the proforma, and tran-
scribed onto a results sheet for the participant by the phy-
sician. The results were explained to the participant by the
physician (using the interpreter as appropriate) who gave
general lifestyle advice for those with blood pressure,
anthropometrical or biochemical measures that indicated
a very low or borderline CVD risk based on Joint British
Society (JBS 2) [7]. For all those asymptomatic partici-
pants with an increased CVD risk score (more than 15%),BMC Health Services Research 2007, 7:192 http://www.biomedcentral.com/1472-6963/7/192
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or BMI > 27 kg/m2, or systolic blood pressure > 140
mmHg or diastolic blood pressure > 85 mmHg (in the
absence of established atherosclerotic disease, diabetes,
and chronic renal failure), or total cholesterol > 5 mmol/
l or diabetes risk (fasting/non-fasting blood glucose > 5
mmol/l), repeat clinical investigations were organised and
the physician developed a management plan that
involved both primary (with culturally sensitive options
for education, lifestyle related risk management and pre-
vention provided by the CHN leader) and secondary care
as appropriate. The criteria for management review was
based on JBS2 guidelines, where those individuals with a
total CVD risk score more than 20% over 10 years were
defined as high risk, and were highlighted for professional
lifestyle intervention. In addition, smoking cessation was
advised to all smoking participants, where the CHN lead
was able to advise culturally targeted options. The consent
process and proforma were approved by the Sandwell
Local Research Ethics Committee.
Analytical methods
All data (where the participant had agreed consent) were
entered for analysis into a statistical database, SPSS v14
(SPSS Inc., Chicago, IL). Continuous data are presented as
mean (standard deviation) and comparisons of means
were analysed by t-test between two independent groups
(eg gender) or ANOVA for multiple groups (ethnic
group), using Tukey for post Hoc analysis. The distribu-
tion of all participants within an age stratification (25–34,
35–44, 45–54 and 65+ years) was used to determine the
age-adjustment needed of all categorical variables within
ethnic groups. An estimate of the 10-year Cardiovascular
Risk Score was made using information gleaned from the
screening process. An estimated HDL cholesterol level of
1 mmol/l was used in all the subjects in calculating the 10
year cardiovascular risk.
Results
Participation within the health screens
A total of 824 (47% male) individuals who attended the
health screens consented for their information to be ana-
lysed. The information was collected from 10 community
health screen events, where community groups such as
the Gujarati Indian, European Caucasian, Punjabi Indian,
Yemeni, Pakistani and Bangladeshi were targeted. Of
these targeted community groups, the attendance at
Gujarati Indian, Punjabi Indian and Yemeni health
screening events was good, with approximately 80 people
(not all people consented for their data to be analysed)
attending. Attendance amongst Bangladeshi and Pakistani
groups was poorer, where less than 50% of our antici-
pated attendance was met. The health screening events
were not exclusive for any particular ethnic group and an
additional category of 'Other Indian subcontinent'
(mostly Sri Lankan, South Indian) are included, which are
merged with the Pakistani cohort (37 individuals) in this
analysis. The largest group who attended the Health
screens were the European Caucasian population (276
out of an anticipated 200 people). A total of ten individu-
als were of Caribbean origin, and are not included in the
analytical analysis due to the size of the group.
Demography and management review
The age range amongst these individuals was 25 to 90
years. The mean (SD) age of the total population was 47.7
(15.2) years, with no significant variation by gender: 48.7
(15.2) years in men, 46.9 (15.1) years in women, (P =
0.09). Across ethnic groups, the mean age differed (P =
0.006). The 'Other Indian subcontinent' group (mean
42.4 years, 95%CI 39.1–45.6) was the youngest compared
to all other ethnic groups, in whom age was comparable
(i.e there were no differences in age between Caucasian,
Gujarati, Bangladeshi, Yemeni and Punjabi). A total of
185 individuals attended the health screening events in a
fasted state, and fasting rates were comparable between
ethnic groups (10–20%), save the Bangladeshi group in
whom 40% attended in a fasting state. With regards to
smoking, all those with a positive response were exclu-
sively current smokers, where age adjusted rates amongst
men (13.4%(95%CI 10.0–16.8)) were almost double
those reported in women (7.7%, (5.2–10.4)). In addition,
smoking habit was generally absent amongst Gujarati,
Punjabi, Bangladeshi women and Yemeni women, and
highest amongst Bangladeshi men. A total of 470 (57%)
individuals were referred by the Healthy Hearts physician
to their general practitioner (there were no cases where a
subject did not have a general practitioner) with a report
of an increased CVD risk, (undetected high blood pressure
in 120 (15%), undetected abnormal blood glucose in 70
(8%), undetected raised total cholesterol in 149 (18%),
and CVD risk management review in 131 (16%)).
Cardiovascular risk profile in communities (Tables 1 and 2)
Within combined communities the overall prevalence of
hypertension was 39.2% (95%CI: 35.9–42.5), half of
whom (19.6% (16.9–22.3)) were newly detected, with no
significant differences in prevalence between different
ethnic groups. Known hyperlipidaemia or active lipid
lowering therapy was reported by 4.2% (2.8–5.6) of the
total population, where 22.6% (19.7–25.5) of all people
screened had newly detected raised total cholesterol (>5
mmol/l) with no significant ethnic variation. The preva-
lence of known diabetes and impaired fasting glucose
were at least 3 times more common in Punjabi, Gujarati,
Bangladeshi and Yemeni groups compared to the Euro-
pean Caucasian population. A total of 555 (67%) individ-
uals who attended the health screens were aged 55 years
or younger. Among these younger participants, 123
(22%) had newly diagnosed raised cholesterol, 89 (16%)BMC Health Services Research 2007, 7:192 http://www.biomedcentral.com/1472-6963/7/192
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had newly diagnosed high blood pressure (16%) and 58
(11%) had newly diagnosed glucose intolerance.
Discussion
Strategies for the prevention of CVD aim to reduce the
prevalence of associated risk factors, particularly amongst
asymptomatic people at high risk of developing or wors-
ening CVD. Screening for, and treatment of, dyslipidae-
mia and hypertension appear to return the largest clinical
benefit compared to the detection of other less tangible
CVD risk factors (albeit to the health professional), such
as smoking habit, diet and anthropometry [19] (specifi-
cally, smoking habit and diet assessment are susceptible
to reporting bias, and appropriate approaches for body
weight and shape cut-offs fuel increasing debate in Asian
countries). However, direct data from CVD risk screening
are not available amongst South Asian or Yemeni groups,
and data from the general population would suggest that
such screening approaches have limited benefit with
respect to improved CVD management [20]. A recent
review investigated the accuracy of CVD risk scoring and
reported that the risk prediction scores generally overesti-
mated observed risk in low risk populations and that there
was no strong evidence that CVD risk assessment per-
formed by the clinician improved health outcomes [11].
However, in high risk populations such as patients with
diabetes [21], or raised socioeconomic deprivation [22],
CVD risk scoring actually underestimated risk. Hence,
within a multi-ethnic inner – city area such as Sandwell,
many high risk individuals may not reach the treatment
threshold. A calibration of the CVD risk score within areas
with high rates of CHD is needed [21].
With specific reference to the JBS2 recommendations in
2005, we would propose that these health screens are not
limited by approaches that focus on the elderly and
should target community groups using multi-lingual
teams.
The uptake of interpreter services was not assessed in this
study. However, amongst the Gujarati, Bangladeshi, Paki-
stani, Punjabi and Yemeni health screening events, inter-
preters and multi-lingual staff were required for the
informed choice process and physician consultation in
more than half of the people that attended. Moreover, we
did not collect information on second- and third-genera-
tion migrants born in the UK, who are less likely to exhibit
the early reported CVD-protective traits, such as low
serum cholesterol and body mass index of the first gener-
ation (born overseas) [23].
Outcomes associated with service delivery arising from
this work are to examine the logistics of establishing
screening programmes to detect hypertension, diabetes
and other CVD risk factors, which are based within the
community utilising community and religious facilities
where the population naturally congregate. By working
with community leaders, the Healthy Hearts project has
developed an effective method of organising health
screening events, not only identifying individuals at risk,
but raising awareness of diabetes, high blood pressure,
heart disease and stroke by health promotion. Further
work is needed to assess the integration of 'at risk' individ-
uals into existing channels of healthcare once cardiovas-
cular problems are highlighted in the community setting.
In the present project, the CHN leaders were present to
consolidate appropriate lifestyle management advice
Table 1: Age adjusted prevalence of cardiovascular risk factors and 10-year coronary heart disease risk score* in men by ethnic group
Age-adjusted prevalence of 
cardiovascular risk 
factors in men
Gujarati Indian 
(n = 43)
Punjabi Indian 
(n = 87)
European 
Caucasian 
(n = 119)
Bangladeshi
 (n = 66)
Yemeni 
(n = 32)
Other Indian
 Subcontinent 
(n = 37)
Known hypertensive 30.2 (16.5–44.0) 27.6 (18.2–37.0) 16.1 (7.2–25.0) 16.1 (7.2–25.0) 26.2 (12.6–43.8) 39.2 (23.4 – 54.9)
Newly diagnosed hypertensive 32.2 (18.2–46.2) 22.0 (13.3–30.8) 29.0 (20.8–37.2) 7.0 (0.8–13.2) 19.3 (5.6–33.0) 24.3 (10.5–38.1)
Known diabetic 11.6 (2.0–21.2) 15.6 (6.7–24.5) 2.6 (0–5.5) 26.3 (15.5–37.0) 9.4 (0–19.6) 0
Newly diagnosed glucose 
intolerance (fasting blood 
glucose > 6 mmol/l)
7.6 (0–15.6) 0 0.7 (0 – 2.1) 8.8 (1.9–15.8) 3.4 (0–9.8) 6.6 (0–15.7)
Known hyperlipidaemia or 
current cholesterol lowering 
therapy
7.3 (0–15.3) 5.7 (0.9–10.6) 1.7 (0 – 4.0) 1.3 (0–4.1) 11.7 (0.5 – 22.8) 3.2 (0–9.1)
Newly diagnosed raised total 
cholesterol (>5 mmol/l)
21.1 (8.7–33.7) 11.6 (4.9–18.4) 24.0 (16.7 – 31.7) 13.2 (5.0–21.4) 21.3 (7.1 – 35.5) 25.9 (11.4–40.4)
Body mass index > 27 kg/m2 43.1 (28.0–58.3) 40.0 (29.7–50.3) 48.4 (39.4–57.4) 48.2 (36.1–60.2) 45.7 (28.5–63.0) 56.2 (39.7–72.6)
Current smoking habit 2.3 (0–6.8) 0 14.7 (21.2) 28.7 (17.8–39.6) 25.0 (9.8–10.3) 11.4 (0.5–22.2)
CHD risk score 10.7 (9.3) 7.6 (6.1) 8.5 (7.1) 9.0 (8.3) 8.5 (6.7) 9.1 (9.0)
Data are percent (95%CI) except *CHD risk score which is mean (SD), calculated with a HDL cholesterol of 1 mmol/l for all subjects. Other Indian 
subcontinent includes Pakistani (17 men), Sri Lankan and South Indian.BMC Health Services Research 2007, 7:192 http://www.biomedcentral.com/1472-6963/7/192
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given by the physician, though their prospective attend-
ance at such programmes was not recorded.
Of note, while rates of diabetes and impaired fasting glu-
cose were more common amongst the South Asian and
Yemeni groups, the prevalence of undetected hyperten-
sion and hyperlipidaemia were comparable across all
groups, which suggests equity in healthcare provision,
albeit for this high risk region. The Health Survey for Eng-
land, which includes information gleaned from a repre-
sentative sample survey in 2004 [24] reflects the known
rates of diabetes amongst South Asian groups reported
here, but levels of hypertension and hyperlipidaemia were
markedly higher amongst our Bangladeshi group. Rates of
smoking were also higher amongst the Bangladeshi male
group, who are the most likely group in Britain to smoke
[1]. The attendance of Bangladeshi and Pakistani groups
at health screening events was considerably less compared
to other ethnic groups targeted. The reasons for this are
not clear, particularly as we included gender specific
health screening events to be sensitive to possible cultural
mannerisms. However, this result highlights the impor-
tance of developing subsequent programs for better com-
munity outreach that will target hard-to-reach subgroups"
The health screening events were started in the morning at
a weekend, which may not have been appropriate for
many Bangladeshi and Pakistani men, who characteristi-
cally work night shifts in the taxi and restaurant busi-
nesses. Of interest, rates of fasting attendance were higher
amongst the Bangladeshi group, and this may be a source
of bias in their attendance and the interpretation of glu-
cose intolerance. In previous research by our group
amongst a representative sample (using random sampling
of the electoral register) of male and female Gujaratis
from the same community presented here [12], we
reported higher rates of known diabetes, current smoking
habit unknown dyslipidaemia and similar rates of hyper-
tension (though rates of known hypertension were much
higher in the present study).
Limitations in our approach include the use of the Fram-
ingham risk equation, where recalibration is needed for
this region of high deprivation and ethnic diversity. The
QRISK equation [25], which identifies and includes dep-
rivation in the estimation of CVD risk and ETHRISK [26],
a modified Framingham CVD risk equation for Black and
Minority groups in Britain were not available at the time
of the project, but would have represented a more appro-
priate option for risk estimation. Moreover, the use of 1
mmol/l as a universal measure of HDL cholesterol
amongst both men and women is likely to contribute to
an overestimation of risk amongst in this project. How-
ever, given our approach to provide health screening par-
ticipants with immediate advice in relation to CVD risk, it
was necessary to estimate a CVD risk score, even in the
absence of a HDL cholesterol measurement (which was
not available as a validated capillary sample approach at
the time of the project). The first line of management of
diabetes, raised cholesterol and hypertension is that of
diet and lifestyle changes. From our research in the
Gujarat [12], it was evident that the diet within the various
communities had changed from traditional practices to
one of higher fat intake and increasing reliance on proc-
Table 2: Age adjusted prevalence of cardiovascular risk factors and 10 yr coronary heart disease risk score* in women by ethnic group
Age adjusted prevalence 
of Cardiovascular risk 
factors in women
Gujarati Indian 
(n = 36)
Punjabi Indian 
(n = 76)
European 
Caucasian 
(n = 157)
Bangladeshi 
(n = 94)
Yemeni 
(n = 36)
Other Indian 
Subcontinent 
(n = 31)
Known hypertension 26.9 (12.4–41.3) 15.2 (7.1–23.2) 12.5 (7.2–17.7) 20.0 (11.9–28.1) 29.6 (14.7–44.5) 5.4 (0–26.7)
Newly diagnosed 
hypertension
15.0 (3.3–26.7) 11.3 (4.2–18.5) 21.3 (6.7–0.5) 13.6 (6.7–20.5) 10.5 (0.5–20.5) 14.1 (0–2.3)
Known diabetes 6.0 (0–13.7) 6.4 (0.1–12.8) 1.7 (0–3.8) 21.3 (13.0–29.6) 13.0 (2.0–23.9) 7.8 (0–10.5)
New glucose intolerance 
(fasting blood glucose > 6 
mmol/l)
16.1 (4.1–28.1) 0 0 5.5 (0.9–10.1) 0 2.2 (0–3.1)
Known hyperlipidaemia 
or cholesterol lowering 
therapy
7.8 (0–16.8) 7.1 (1.3–12.8) 2.1 (0–4.4) 8.2 (2.7–13.8) 8.8 (0–18.1) 8.7 (0–47.8)
Newly diagnosed raised 
total cholesterol (>5 
mmol/l)
32.2 (16.6–48.0) 14.0 (6.2–21.8) 36.8 (29.1–44.5) 17.2 (9.6–24.8) 11.2 (0.9–21.4) 17.6 (0–70.5)
Body mass index > 27 kg/
m2
37.6 (21.4–53.9) 50.1 (38.8–61.3) 43.7 (35.8–51.5) 47.2 (37.1–57.3) 49.5 (33.1–65.8) 41.0 (0–109)
Current smoking habit 0 3.1 (0–7.0) 18.8 (12.6–25.0) 0.8 (0–2.6) 0 0
CHD risk score 6.89 (8.35) 6.60 (5.77) 5.56 (5.27) 6.60 (7.00) 5.60 (8.29) 4.39 (5.15)
Data are percent (95%CI) except *CHD risk score which is mean (SD), calculated with a HDL cholesterol of 1 mmol/l for all subjects. Other Indian 
Subcontinent includes Pakistani (20 women) and South Indian.BMC Health Services Research 2007, 7:192 http://www.biomedcentral.com/1472-6963/7/192
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essed foods. Of note, dietary advice that was culturally
sensitive was not available at the time of this project for
many of the individuals that attended health screening
events.
Conclusion
Within the communities assessed, the present data show
that there is a demand and need for the assessment of dia-
betes, hypertension, and CVD risk in adults, even among
younger people, from the age of 25 years. Using this sys-
tematic and targeted approach, an average of eighty peo-
ple from various ethnic backgrounds attended the one-
day screening events, of whom half needed review from
primary or secondary healthcare. Importantly, the
approach engaged the local communities in health pro-
motion and allowed immediate medical attention to
reduce CVD risk. The implication of these findings is that
there is a role for this targeted approach to CVD risk
screening in high risk areas such as Sandwell to widen the
access of the community to existing primary and second-
ary CVD healthcare services and promote healthy living.
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